601 filings
Page 5 of 31
4
guw4ea z42n6k
7 Mar 23
Corbus Pharmaceuticals / Yong Ben ownership change
10:19am
3
3w0dkwimemnhkskg3tix
7 Mar 23
Corbus Pharmaceuticals / Yong Ben ownership change
10:14am
8-K
49bthrky
7 Mar 23
Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update
9:01am
8-K
9paxh2opv6efmyhbf7i
6 Mar 23
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
9:01am
4
axyck ss7
15 Feb 23
Corbus Pharmaceuticals / Rachael Louise Brake ownership change
12:56pm
4
ey1g4evbwl0
15 Feb 23
Corbus Pharmaceuticals / Craig Stuart Millian ownership change
12:53pm
4
pqt vmeem738jyzh
15 Feb 23
Corbus Pharmaceuticals / Sean F. Moran ownership change
12:51pm
4
5ikw1szbs3iaeq62 it1
15 Feb 23
Corbus Pharmaceuticals / Yuval Cohen ownership change
12:44pm
8-K/A
hj15cx4yhg7 oenz
14 Feb 23
Material Modifications to Rights of Security Holders
6:13pm
8-K
0jt99le3z wggpzq9d
13 Feb 23
CRB-701 (SYS6002) is designed for improved therapeutic index and to act on a broad range of Nectin-4 expressing tumors
8:00am
8-K
q1aie20igqe4css7m3hc
6 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:58pm
8-K
fhy16sx
21 Dec 22
Submission of Matters to a Vote of Security Holders
4:42pm
8-K
f5vw 7zhgp
21 Dec 22
Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:35pm
8-K
h1p wd3ua1tweu
31 Oct 22
Entry into a Material Definitive Agreement
5:30pm
8-A12G
l09zse
12 Oct 22
Registration of securities
5:08pm
8-K
i4ewadvpkk ve2e
12 Oct 22
Material Modifications to Rights of Security Holders
4:40pm
4
42hw0xq6ok6eq6
28 Sep 22
Corbus Pharmaceuticals / Anne Altmeyer ownership change
9:38am